Through genuine partnership with our customers, in the Life Science industry, HORIBA will develop and deliver, innovative analytical and automation solutions, combining state-of-the-art, optical, electrochemical, and X-ray technologies, with core competencies in sampling, engineering and data science. HORIBA will contribute to breakthroughs in drug development and manufacturing, leading to the adoption of new technologies, and contributing to a healthier, more affordable and more equitable health care for all.
HORIBA is proud to announce that the Veloci™ BioPharma Analyzer has been selected by The Analytical Scientist as one of its Top 10 Most Innovative…
HORIBA is proud to announce the release of the RZ-660 In Vivo Raman Analyzer, a benchtop instrument designed for real-time, non-invasive molecular…
Aqualog®-Next is a dual-function spectrometer that simultaneously acquires absorbance and fluorescence excitation-emission matrices (EEMs) using…
Aiming to Commercialize Industry-first Continuous Electroporation Technology
HORIBA proudly announces the launch of the PoliSpectra® Rapid Raman Plate Reader (RPR) for Raman High-Throughput Screening (HTS).
The BioPharma Analyzer is a unique A-TEEM™ spectroscopy solution for the biopharma and pharma industries that combines the selectivity of…
HORIBA is proud to announce an expanded portfolio of instruments tailored to meet the rigorous demands of the pharmaceutical industry.
HORIBA is proud to announce the launch of InverTau™, a new platform for confocal fluorescence lifetime imaging.
A-TEEM Technology with Multivariate Analysis Speeds up Data Evaluation
Masz pytania lub prośby? Skorzystaj z tego formularza, aby skontaktować się z naszymi specjalistami.
